Welcome to MyStrategist.

MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.

e-Newsletter   Browse
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Business Strategies

TISSIUM’s Biotech-Like Business Model for Tissue Repair

To commercialize its multi-faceted tissue repair technology, TISSIUM is relying on a business model that will see it develop and commercialize some applications on its own and others in collaboration with larger, well-established partners. Excerpted from MedTech Strategist's recent feature on TISSIUM.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Investors & Dealmaking

Digital Health Funding YTD Tops Full-Year 2020

Digital health investment is now at an all-time high, according to Rock Health’s most recent report on H1 2021 funding trends. Excerpted from MedTech Strategist's recent feature, "Digital Health Deals Soar in First Half of 2021."

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Regulatory & Reimbursement

Pathways’ Pick of the Week: China Clarifies Combination Products Rules

The National Medical Products Administration updated its policies and issued a draft guidance on designation and submissions of single-entity drug-device combination products. Importantly, NMPA made its submission requirements more flexible. Excerpted from Pathways’ Picks July 27.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
More From Community Blog: